Semi Glizid-M Tablet
By Glizid-M
Rx
10 Tablet in a Strip

Composition
Gliclazide(40mg) + Metformin(500mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
June, 2026

liver
When using Semi Glizid-M Tablet Tablet, it's important to be cautious if you have liver disease. Your doctor may need to adjust your dose accordingly, so it's essential to consult with them before starting this medication. Typically, Semi Glizid-M Tablet Tablet is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advisable for patients with severe liver disease. Please prioritize discussing your liver condition with your healthcare provider before using Semi Glizid-M Tablet Tablet.

kidney
Use Semi Glizid-M Tablet Tablet carefully if you have kidney disease. Dose may need adjustment, so consult your doctor. Not recommended for severe kidney disease. Regular kidney function tests are advisable during treatment.

alcohol
Avoid alcohol while taking Semi Glizid-M Tablet Tablet.

driving
Do not drive if you experience symptoms of low or high blood sugar with Semi Glizid-M Tablet Tablet as it may affect your driving ability.

pregnancy
Semi Glizid-M Tablet Tablet is considered unsafe during pregnancy due to potential risks to the developing baby. Consult your doctor for advice, as it may be prescribed in certain critical situations where benefits outweigh risks.

breastfeeding
Semi Glizid-M Tablet Tablet is likely unsafe during breastfeeding, as it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹44
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024